The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Pulmonary complications in survivors of childhood and adolescent cancer: A report from the Childhood Cancer Survivor Study
Open accessAbstract
BACKGROUND: The Childhood Cancer Survivor Study is a resource that was designed to investigate long‐term effects among 5‐year survivors of childhood and adolescent malignancies. Previous studies have shown that exposure to chemotherapy and/or radiation can compromise pulmonary function in these survivors of childhood cancer. METHODS: Using information obtained from questionnaires from 12,390 childhood cancer survivors and 3546 randomly selected siblings, the authors evaluated the rate of first occurrence of 15 selected pulmonary conditions in three periods: during therapy, from the end of therapy to 5 years postdiagnosis, and ≥ 5 years postdiagnosis. Multivariate analyses were used to determine the relative risks with 95% confidence intervals of reported pulmonary conditions by exposure to the following treatment variables: radiation therapy to the chest, bleomycin, cyclophosphamide, busulfan, lomustine (CCNU), and/or carmustine (BCNU). RESULTS: Compared with siblings, survivors had a statistically significant increased relative risk (RR) of lung fibrosis, recurrent pneumonia, chronic cough, pleurisy, use of supplemental oxygen, abnormal chest wall, exercise‐induced shortness of breath, bronchitis, recurrent sinus infection, and tonsillitis for all three periods. During the period of ≥ 5 years postdiagnosis, statistically significant associations were present for lung fibrosis and chest radiation (RR, 4.3; P = 0 001); for supplemental oxygen use and chest radiation (RR, 1.8; P < 0.001), BCNU (RR, 1.4; P = 0.05), bleomycin (RR, 1.7; P = 0.001), busulfan (RR, 3.2; P = 0.002), CCNU (RR, 2.1; P < 0.001), and cyclophosphamide (RR, 1.5; P = 0.01); for recurrent pneumonia and chest radiation (RR, 2.2; P = 0.001) and cyclophosphamide (RR, 1.6; P = 0.04); for chronic cough and chest radiation (RR, 2.0; P < 0.001), bleomycin (RR, 1.9; P < 0.001), and cyclophosphamide (RR, 1.3; P = 0.004); and for pleurisy and chest radiation (RR, 1.4; P = 0.02) and busulfan (RR, 5.1; P = 0.02). Chest radiation was associated with a 3.5% cumulative incidence of lung fibrosis at 20 years after diagnosis. CONCLUSIONS: For self‐report of pulmonary conditions, treatment‐related factors that continue to manifest > 5 years after diagnosis and treatment are important determinants of risk. Continued follow‐up of childhood cancer survivors is needed to evaluate the impact of pulmonary conditions on quality of life. Cancer 2002;95:2431–41. © 2002 American Cancer Society. DOI 10.1002/cncr.10978
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
Gooley, T. A., Leisenring, W., Crowley, J., & Storer, B. E. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990330)18:6<695::aid-sim60>3.0.co;2-o · Cited by 2,688
Mertens, A. C., Yasui, Y., Neglia, J. P., Potter, J. D., Nesbit, M. E., Ruccione, K., Smithson, W. A., & Robison, L. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.13.3163 · Cited by 798
Self-citationRobison, L. L., Mertens, A. C., Boice, J. D., Breslow, N. E., Donaldson, S. S., Green, D. M., Li, F. P., Meadows, A. T., Mulvihill, J. J., Neglia, J. P., et al. (2002) · Medical and Pediatric Oncology · doi:10.1002/mpo.1316 · Cited by 696
Self-citationLung Cancer Following Chemotherapy and Radiotherapy for Hodgkin's Disease
Travis, L. B. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.3.182 · Cited by 562
Latency of asbestos disease among insulation workers in the United States and Canada
Selikoff, I. J., Hammond, E. C., & Seidman, H. (1980) · Cancer · doi:10.1002/1097-0142(19801215)46:12<2736::aid-cncr2820461233>3.0.co;2-l · Cited by 306
Radiation-induced and chemotherapy-induced pulmonary injury
Abid, S. H., Malhotra, V., & Perry, M. C. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200107000-00006 · Cited by 274
Active Lung Fibrosis up to 17 Years after Chemotherapy with Carmustine (BCNU) in Childhood
O’Driscoll, B. R., Hasleton, P. S., Taylor, P. M., Poulter, L. W., Gattamaneni, H. R., & Woodcock, A. A. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008093230604 · Cited by 238
The pulmonary toxicity of antineoplastic agents.
Ginsberg, S. J., & Comis, R. L. (1982) · PubMed · Cited by 235
Emmons, K. M., Li, F. P., Whitton, J., Mertens, A. C., Hutchinson, R., Diller, L., & Robison, L. L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1608 · Cited by 186
Self-citationRadiation pneumonitis: Experience following a large single dose of radiation
Fryer, C. J. H., Fitzpatrick, P. J., Rider, W. D., & Pooh, P. (1978) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(78)90002-0 · Cited by 177
Pulmonary toxicity of antineoplastic agents
Green, M. R. (1983) · Reactions Weekly · doi:10.1007/bf03265251 · Cited by 137
Lung function and exercise capacity in survivors of childhood leukaemia
Jenney, M. E. M., Faragher, E. B., Jones, P. H. M., et al. (1995) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950240403 · Cited by 118
Taylor, J. M., Muñoz, A., Bass, S. M., Saah, A. J., Chmiel, J. S., & Kingsley, L. (1990) · PubMed · doi:10.1002/sim.4780090504 · Cited by 97
Effects of pulmonary function of whole lung irradiation for Wilm's tumour in children.
Benoist, M. R., Lemerle, J., Jean, R., Rufin, P., Scheinmann, P., & Paupe, J. (1982) · Thorax · doi:10.1136/thx.37.3.175 · Cited by 91
Effects of Therapeutic Irradiation Delivered in Early Childhood Upon Subsequent Lung Function
Wohl, M. E. B., Griscom, N. T., Traggis, D., & Jaffe, N. (1975) · PEDIATRICS · doi:10.1542/peds.55.4.507 · Cited by 87
Cited by
Cancer treatment and survivorship statistics, 2012
Siegel, R., DeSantis, C., Virgo, K., Stein, K., Mariotto, A., Smith, T., Cooper, D., Gansler, T., Lerro, C., Fedewa, S., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21149 · Cited by 2,928
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
Robison, L. L., & Hudson, M. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3634 · Cited by 857
Self-citationMertens, A. C., Liu, Q., Neglia, J. P., Wasilewski, K., Leisenring, W., Armstrong, G. T., Robison, L. L., & Yasui, Y. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn310 · Cited by 730
Self-citationRobison, L. L., Armstrong, G. T., Boice, J. D., Chow, E. J., Davies, S. M., Donaldson, S. S., Green, D. M., Hammond, S., Meadows, A. T., Mertens, A. C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.3339 · Cited by 669
Self-citationChronic Disease in the Childhood Cancer Survivor Study Cohort: A Review of Published Findings
Diller, L., Chow, E. J., Gurney, J. G., Hudson, M. M., Kadan-Lottick, N. S., Kawashima, T. I., Leisenring, W. M., Meacham, L. R., Mertens, A. C., Mulrooney, D. A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.1953 · Cited by 415
Self-citation
Metadata
- Authors
- Mertens, A. C., Yasui, Y., Liu, Y., Stovall, M., Hutchinson, R., Ginsberg, J., Sklar, C., & Robison, L. L.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2002-11-19
- Volume
- 95
- Issue
- 11
- Pages
- 2431-2441
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2043122396
- Cited by
- 298
- References
- 17
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.